Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #10763 on Quanta Inc (fka QNTA)
~MulaGreen~
09/29/21 8:44 AM
#10764 RE: ~MulaGreen~ #10763
In addition to surpassing the expectations from the MOE, the Company also received interest from the MOE in purchasing Escozine®, Medolife’s lead drug candidate. The report included clinical observations made by the Company on the potential therapeutic and palliative properties of Escozine® in patients who have tested positive for the SARS-CoV-2 (COVID-19) virus, and preventative properties in hospital staff that reported zero new infections over the course of the clinical observation. The MOE is interested in purchasing Escozine® as a preventative alternative medicine for its employees.
powerbattles
09/29/21 3:27 PM
#10774 RE: ~MulaGreen~ #10763